USE OF PVDF MEMBRANE TO PURIFY CELL-BINDING AGENT - CYTOTOXIC AGENT CONJUGATES Russian patent published in 2018 - IPC A61K39/395 A61P35/00 B01D39/14 C12M1/12 

Abstract RU 2661083 C2

FIELD: biochemistry.

SUBSTANCE: disclosed is a method obtaining a purified cell-binding agent - cytotoxic agent conjugate (embodiments). In the first embodiment, the method comprises bringing the cell-binding agent into contact with a cytotoxic agent to form a first mixture, bringing the first mixture into contact with a linker-containing bifunctional crosslinking agent to form a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the second mixture to obtain a purified mixture of the cell-binding agent-cytotoxic agent conjugate. In a second embodiment, the method comprises bringing the cell-binding agent into contact with a linker-containing bifunctional cross-linking agent to produce a first mixture, treating the first mixture to produce a purified first mixture, conjugating a cytotoxic agent with bound linker-containing cell-binding agents to obtain a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the second mixture to obtain a purified mixture of the cell-binding agent-cytotoxic agent conjugate. In a third embodiment, the method comprises bringing the cell-binding agent into contact with a linker-containing bifunctional cross-linking agent to form a first mixture, conjugating a cytotoxic agent with bound linker-containing cell-binding agents to obtain a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the purified second mixture to obtain a purified cell-binding agent-cytotoxic agent conjugate mixture.

EFFECT: invention enables preparation of a cell-binding agent-cytotoxic agent conjugate with higher purity and stability.

178 cl, 2 dwg, 3 tbl, 5 ex

Similar patents RU2661083C2

Title Year Author Number
METHOD OF PRODUCING CONJUGATES OF CELL-BINDING AGENT AND CYTOTOXIC AGENT 2015
  • Hutchins Benjamin M.
RU2711930C2
CREATION OF CONJUGATES OF GD2-SPECIFIC ANTIBODIES AND FRAGMENTS OF GD2-SPECIFIC ANTIBODIES WITH PREPARATIONS 2019
  • Kholodenko Roman Vasilevich
  • Doronin Igor Igorevich
  • Larin Sergei Sergeevich
  • Kibardin Aleksei Vladimirovich
  • Rozov Fedor Nikolaevich
  • Kholodenko Irina Viktorovna
RU2733430C1
METHODS FOR PREPARING ANTIBODY-DRUG CONJUGATE COMPOSITIONS 2015
  • Pejn Dzhillian
  • Kherbst Robert V.
  • Bridzhuoter Dzhuma
RU2741470C2
CD37-BINDING MOLECULES AND THEIR IMMUNOCONJUGATES 2011
  • Dekert Dzhutta
  • Park Piter
  • Tavares Deniel
  • Rui Linyun
RU2742743C2
ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE 2011
  • Eb Olga
  • Tavares Deniel
  • Rui Linyun
  • Pejn Dzhillian
  • Goldmakher Viktor S.
RU2740479C2
ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE 2019
  • Chen, Yvonne
  • Dennis, Mark
  • Dornan, David
  • Elkins, Kristi
  • Junutula, Jagath, Reddy
  • Polson, Andrew
  • Zheng, Bing
RU2791984C2
NEW ANTI-CD19 ANTIBODIES 2018
  • Li, Jing
  • Liu, Jieying
RU2791445C2
DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS 2014
  • Sakhin Ugur
  • Tyurechi Ozlem
  • Valter Korden
  • Vagner Majke
  • Krojtsberg Mariya
  • Kheker Sabine
  • Yakobs Shtefan
RU2749867C2
CONJUGATES OF ANTIBODY TO CCR7 AND DRUG 2018
  • Bender, Steven
  • Charlton, Tracy
  • Galkin, Anna
  • Geierstanger, Bernhard Hubert
  • Glaser, Scott Martin
  • Kasibhatla, Shailaja
  • Knuth, Mark
  • Rottmann, Sabine
  • Rue, Sarah
  • Spraggon, Glen
  • Uno, Tetsuo
RU2777662C2
METHODS OF OBTAINING, PURIFICATION AND COMPOSING OF ANTIBODY-DRUG CONJUGATES 2019
  • Milano, Deniel F.
  • Reardon, Majkl R.
  • Silva, Richard A.
  • Khatchins, Bendzhamin M.
  • Kherbst, Robert V.
RU2801229C2

RU 2 661 083 C2

Authors

Chen Syaosi Kevin

Li Sinfan

Dates

2018-07-11Published

2013-10-04Filed